Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Comparison of total and salivary cortisol in a low-dose ACTH (Synacthen) test: influence of three-month oral contraceptives administration to healthy women

K. Simůnková, L. Stárka, M. Hill, L. Kríz, R. Hampl, K. Vondra

. 2008 ; 57 (Suppl 1) : S193-S199.
. 2008 ; 57 (Suppl 1) : S193-S199.

Language English Country Czech Republic

Document type Clinical Trial, Comparative Study, Journal Article, Research Support, Non-U.S. Gov't

Grant support
NR9154 MZ0 CEP Register

The objective of this study was to evaluate the influence of low-dose combined oral contraception (COC) on basal and stimulated (1 microg ACTH test) levels of serum and salivary cortisol (F), cortisone and on basal serum cortisol binding globulin (CBG), adrenocorticotropic hormone (ACTH), dehydroepiadrosterone (DHEA) and calculated free cortisol in healthy young women. Three-month administration of COC resulted in 1) significant increase of basal (454.0+/-125.0 to 860.9+/-179.7 nmol/l) and ACTH-stimulated serum cortisol in 30th min (652.3+/-60.5 to 1374.1+/-240.6 nmol/l); 2) no significant change of basal (15.4+/-7.3 to 18.9+/-8.5 nmol/l) and ACTH-stimulated salivary cortisol at the 30th min (32.4+/-8.8 to 32.9+/-9.0 nmol/l); 3) no significant change of basal serum cortisone (38,8+/-7.68 to 45.2+/-24.2 nmol/l) and ACTH-stimulated cortisone at the 30th (34.8+/-10.9 to 47.0+/-35.7 nmol/l); 4) significant increase of basal ACTH (17.2+/-9.0 to 38.2+/-29.4 ng/l), CBG (991.0+/-161.0 to 2332.0+/-428.0 nmol/l), and 5) no significant change of basal DHEA (24.6+/-15.7 to 22.6+/-11.7 micromol/l) and calculated basal value for free cortisol (22.8+/-14.9 to 19.2+/-6.9 nmol/l). In conclusions, higher basal and ACTH-stimulated serum cortisol were found after three-month administration of COC, while basal and stimulated salivary cortisol were not significantly affected. Therefore, salivary cortisol can be used for assessment of adrenal function in women regularly using COC.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13034126
003      
CZ-PrNML
005      
20151006120557.0
007      
ta
008      
131021s2008 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.931505 $2 doi
035    __
$a (PubMed)18271677
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Šimůnková, Kateřina $u Institute of Endocrinology, Prague, Czech Republic. ksimunkova@endo.cz $7 xx0143534
245    10
$a Comparison of total and salivary cortisol in a low-dose ACTH (Synacthen) test: influence of three-month oral contraceptives administration to healthy women / $c K. Simůnková, L. Stárka, M. Hill, L. Kríz, R. Hampl, K. Vondra
520    9_
$a The objective of this study was to evaluate the influence of low-dose combined oral contraception (COC) on basal and stimulated (1 microg ACTH test) levels of serum and salivary cortisol (F), cortisone and on basal serum cortisol binding globulin (CBG), adrenocorticotropic hormone (ACTH), dehydroepiadrosterone (DHEA) and calculated free cortisol in healthy young women. Three-month administration of COC resulted in 1) significant increase of basal (454.0+/-125.0 to 860.9+/-179.7 nmol/l) and ACTH-stimulated serum cortisol in 30th min (652.3+/-60.5 to 1374.1+/-240.6 nmol/l); 2) no significant change of basal (15.4+/-7.3 to 18.9+/-8.5 nmol/l) and ACTH-stimulated salivary cortisol at the 30th min (32.4+/-8.8 to 32.9+/-9.0 nmol/l); 3) no significant change of basal serum cortisone (38,8+/-7.68 to 45.2+/-24.2 nmol/l) and ACTH-stimulated cortisone at the 30th (34.8+/-10.9 to 47.0+/-35.7 nmol/l); 4) significant increase of basal ACTH (17.2+/-9.0 to 38.2+/-29.4 ng/l), CBG (991.0+/-161.0 to 2332.0+/-428.0 nmol/l), and 5) no significant change of basal DHEA (24.6+/-15.7 to 22.6+/-11.7 micromol/l) and calculated basal value for free cortisol (22.8+/-14.9 to 19.2+/-6.9 nmol/l). In conclusions, higher basal and ACTH-stimulated serum cortisol were found after three-month administration of COC, while basal and stimulated salivary cortisol were not significantly affected. Therefore, salivary cortisol can be used for assessment of adrenal function in women regularly using COC.
650    _2
$a nemoci nadledvin $x diagnóza $x metabolismus $7 D000307
650    _2
$a adrenokortikotropní hormon $x aplikace a dávkování $x krev $x diagnostické užití $7 D000324
650    _2
$a dospělí $7 D000328
650    _2
$a transportní proteiny $x krev $7 D002352
650    _2
$a kontraceptiva orální $x aplikace a dávkování $7 D003276
650    _2
$a kortison $x krev $x metabolismus $7 D003348
650    _2
$a dehydroepiandrosteron $x krev $7 D003687
650    _2
$a lékové interakce $7 D004347
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hydrokortison $x krev $x metabolismus $7 D006854
650    _2
$a hypofyzoadrenální funkční testy $7 D010912
650    _2
$a referenční hodnoty $7 D012016
650    _2
$a sliny $x metabolismus $7 D012463
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Stárka, Luboslav, $u Institute of Endocrinology, Prague, Czech Republic $d 1930- $7 jn19990209795
700    1_
$a Hill, Martin, $u Institute of Endocrinology, Prague, Czech Republic $d 1962- $7 mzk2005304431
700    1_
$a Kříž, Lubomír $u Institute of Endocrinology, Prague, Czech Republic $7 xx0118373
700    1_
$a Hampl, Richard, $u Institute of Endocrinology, Prague, Czech Republic $d 1941- $7 jo20000074077
700    1_
$a Vondra, Karel, $u Institute of Endocrinology, Prague, Czech Republic $d 1943- $7 jo20000074105
773    0_
$w MED00003824 $t Physiological research $x 0862-8408 $g Roč. 57,Suppl 1 (2008), s. S193-S199
773    0_
$t From clinical to molecular endocrinology $x 0862-8408 $g Roč. 57,Suppl 1 (2008), s. S193-S199 $w MED00170142
856    41
$u http://www.biomed.cas.cz/physiolres/archive.htm $y domovská stránka časopisu - plný text volně přístupný = fulltext
910    __
$a ABA008 $b A 4120 $c 266 $y 3 $z 0
990    __
$a 20131021 $b ABA008
991    __
$a 20151006120742 $b ABA008
999    __
$a ok $b bmc $g 998526 $s 832596
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2008 $b 57 $c Suppl 1 $d S193-S199 $i 0862-8408 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2008 $b 57 $c Suppl 1 $d S193-S199 $i 0862-8408 $m From clinical to molecular endocrinology $n $x MED00170142
GRA    __
$a NR9154 $p MZ0
LZP    __
$b NLK138 $a Pubmed-20131021

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...